Revvity reported $2.63B in Loan Capital for its fiscal quarter ending in September of 2026.





Loan Capital Change Date
Agilent USD 3.64B 594M Jun/2026
Align Technology USD 0 0 Dec/2024
Bio Techne USD 200M 0 Jun/2026
Bio-Rad Laboratories USD 803.1M 100K Sep/2026
Bruker USD 1.7B 111.7M Sep/2026
Celltrion KRW 412.88B 1.61B Jun/2026
Charles River Laboratories USD 2.44B 176.52M Sep/2026
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Danaher USD 24.39B 759M Sep/2026
Dentsply International USD 1.98B 11M Sep/2026
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 40M 10M Sep/2026
Edwards Lifesciences USD 598.8M 100K Sep/2026
Illumina USD 1.79B 298M Sep/2026
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 14.82B 1.12B Sep/2026
Kangmei Pharma CNY 67.35M 1.22M Jun/2026
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
Laboratory Of America USD 5.31B 607.4M Sep/2026
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.5M 167K Dec/2025
Mesa Laboratories USD 104.2M 104.3M Sep/2024
Mettler Toledo International USD 1.96B 81.23M Sep/2026
Myriad Genetics USD 120.7M 400K Jun/2026
OraSure Technologies USD 100K 17K Dec/2025
Organigram Holdings CAD 17.61M 43.15M Jun/2026
Ovoca Bio EUR 0 0 Jun/2021
Pacific Biosciences Of California USD 645.38M 223K Dec/2025
Pharma Mar EUR 36.24M 4.11M Sep/2026
Qiagen NV USD 1.63B 19.45M Jun/2026
Quest Diagnostics USD 5.54B 92M Sep/2026
Quidel USD 2.51B 22.5M Sep/2026
Repligen USD 555.6M 4.55M Sep/2026
Revvity USD 2.63B 968K Sep/2026
Sartorius EUR 3.43B 216.6M Sep/2026
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Thermo Fisher Scientific USD 39.11B 73M Sep/2026
Tilray USD 268.59M 3.82M Sep/2025
Waters USD 5.09B 129M Jun/2026
Zealand Pharma A/S 307M 76.14M Mar/2026
Zz Pientze Pharmaceu CNY 160.45M 12.35M Sep/2026